NUVA | NuVasive, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	39.51 - 40.96
52 Week Range	35.17 - 49.53
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	30,593,998
Average Volume	1,414,938
Shares Outstanding	52,449,200
Market Cap	2,084,855,700
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2004-05-13

Valuation
Profitability
Growth
Health
P/E Ratio	75.00
Forward P/E Ratio	26.00
EPS	0.53
1YR Price Target	60.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	3,000
Country	USA
Website	NUVA

NuVasive Inc is a medical device company focused on minimally invasive surgical products and integrated solutions for spine surgery. The firm's spine surgery products contribute to the majority of revenue. Its key offering is the maximum access surgery minimally disruptive surgical platform, which minimizes soft-tissue disruption and contact with critical nerves and maximizes visualization during spine fusion surgery. NuVasive also develops biologics used to aid in the spinal fusion or bone-healing processes, such as a collagen-based synthetic bone substitute and synthetic bone-graft material. NuVasive generates the majority of its revenue in the United States.

NUVA's peers: AORT, ARAY, ATEC, AVNS, AXGN, BRKR, CERS, CNMD, CUTR, FNA, GKOS, GMED, IART, INGN, IRTC, ITGR, KIDS, LIVN, LUNG, MASI, NPCE, NVRO, OFIX, OM, PHG, QDEL, RBOT, SGHT, SIBN, SNN, SRDX, STE, VREX, ZBH, ZIMV

*Chart delayed

Analyzing fundamentals for NUVA we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is unacceptably poor, Growth is good and Health is very weak. For more detailed analysis please see NUVA Fundamentals page.

Watching at NUVA technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on NUVA Technicals page.